Home
Welcome
The Trinity Biomedical Sciences Institute (TBSI) is an environment where innovative and interdisciplinary approaches are leading to scientific discoveries of biomedical importance, ultimately giving rise to better patient care.
News
-
TBSI Covid-19 Planview TBSI Covid-19 Plan ." -
Is reaching zero COVID-19 possible?.by Kingston Mills" -
Landmark deal for UQ-Trinity inflammation startup.Uniquest news ." -
Speed, success, diplomacy and delivery: the formula for a Covid-19 vaccineIrish Times article by Claire O’Connell." -
TCD scientists researching treatments for Covid-19Irish Times article by George Lee Environment and Science Correspondent." -
Further investment in COVID-19 Research ProjectTrinity College Dublin has welcomed the Government’s €4.8M investment into a collaborative partnership at the university researching the immune response to COVID-19." -
TCD: response to Covid-19link to TCD website on their response to Covid-19."
-
#IrelandinSF VIRTUAL Speaker SeriesJoin us for this webinar #IrelandinSF Virtual Speaker Series, “Ireland’s Research Response to the Covid-19 Crisis and Transatlantic Scientific Cooperation” with Dr Siobhan Roche and Prof Kingston Mills in conversation with Dr Máire Quigley" -
Covid-19 immunology projectJoin Professor Kingston Mills, Aideen Long and Luke O’Neill for this webinar on 27 May at 13:00" -
Kingston Mills, Covid-19 immunology projectProfessor Kingston Mills, Business Post podcast, with Nadine O’Regan" -
Global effort to develop a blend of drugs to control Covid-19 is under wayProfessor Kingston Mills, Irish Times" -
TBSI Research Role, Covid-19The Trinity COVID-19 Immunology Project will be powered from Trinity Biomedical Sciences Institute, Ireland’s largest biomedical research facility and home to the greatest critical mass of internationally recognised immunologists and scientists in Ireland, including Kingston Mills, Professor of Experimental Immunology and Luke O’Neill FRS, Chair of Biochemistry"
-
TBSI Covid-19 research hub, Prof Kingston Mills, is co-leading the projectAccording to Professor Mills "This will provide key information for the design of vaccines and immunotherapeutic drugs for controlling the often fatal inflammation in Covid-19 patients, and will assist in developing and validating new assays for detecting antibody responses to the virus, thereby identifying those who are ‘immune’ and therefore safe to return to work."
-
Sitryx announces major licensing and research collaboration with LillySitryx was co-founded by Luke O’Neill, professor of biochemistry at Trinity, in 2018, partly based on discoveries made in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute (TBSI) -
Behind the Headlines discussion Plagues and Pandemics which was livestreamed to over 7000 viewers on Thursday evening, March 26th 2020 -
President of Ireland Michael D Higgins, has honoured four Trinity College researchers as recipients of the SFI President of Ireland Future Research Leaders Awards at a special ceremony in Áras an Uachtaráin, DublinDr David Loane is researching traumatic brain injury and sustained brain inflammation linked to dementia and chronic neurodegeneration -
Trinity scientists discover new “Jekyll and Hyde” immune cellThe research was funded by Science Foundation Ireland and led by Kingston Mills, Professor of Experimental Immunology, and Dr Sarah Edwards and Dr Caroline Sutton, Postdoctoral Fellows in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute. Their findings were published 27 February 2020 in The Journal of Experimental Medicine. -
TBSI Scientists with asthma breakthrough, published in Nature Communications 26 February 2020Lead author Zbigniew Zaslona, working with a team led by Luke O’Neill, Professor of Biochemistry in the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute, has been exploring the role that inflammation plays in asthma – a very common and often serious disease of childhood -
Traumatic brain injury,‘Resetting’ immune cells improves traumatic brain injury recovery in preclinical trials, published in Journal of NeuroscienceDavid Loane, Research assistant professor in Trinity’s School of Biochemistry and Immunology, TBSI, Dr David Loane led the exciting new research.
-
Cardiac Patches, published in Advanced Functional MaterialsMichael Monaghan, Ussher Assistant Professor in Biomedical Engineering at TBSI, senior author on the paper along with Dinorath Olvera, Mina Sohrabi Molina and Gillian Hendy. -
New discovery provides hope for improved MS therapiesled by Kingston Mills, Professor of Experimental Immunology, and Aoife McGinley, Postdoctoral Fellow, in Trinity’s School of Biochemistry and Immunology .
-
How bacterial evolution of antibiotic arsenals is providing new blueprints for drug designersProfessor Martin Caffrey, Fellow Emeritus in Trinity’s School of Biochemistry and Immunology, is the senior author of the research article. -
TBSI Scientists discover how TB puts the brakes on our immune enginesSFI-funded Starting Investigator Research Grant, Frederick Sheedy, Ussher Assistant Professor in the School of Biochemistry and Immunology at Trinity, mentored by St James’ Hospital TB specialist, Professor Joseph Keane, has been examining how these lung macrophage immune cells fuel the fight against infection.
